FilingReader Intelligence
CSPC Pharmaceutical Group's 2024 profit drops amid industry shifts
March 28, 2025 at 05:18 PM UTC•By FilingReader AI
CSPC Pharmaceutical Group (HKEX: 1093) announced its annual results for the year ended December 31, 2024, revealing a profit of RMB 4.328 billion, down from RMB 5.873 billion in 2023. Underlying profit attributable to shareholders, which excludes fair value losses on financial assets and other items, decreased by 25.4% to RMB 4.683 billion.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
HKEX:1093•Hong Kong Exchange
News Alerts
Get instant email alerts when CSPC Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime